Skip to main content
Back
Watch Compare

ROCKET PHARMACEUTICALS, INC.

Data quality: 100%
RCKTW
NASDAQ Manufacturing Chemicals
$0.02
▲ $0.01 (119.32%)
Mkt Cap: 977,889.0
Price
$0.01
Mkt Cap
977,889.0
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -190.45 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-66.82%
Below sector avg (-54.01%)
ROIC-51.25%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio7.30
Interest Coverage-122.55

Valuation

PE (TTM)
0.00
Above sector avg (-1.49)
P/B Ratio0.00
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E 0.0 -1.5
P/B 0.0 1.6
ROE % -66.8 -54.0
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 — 18.47 M —
FY2026 — 18.17 M —

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -223.12 M
ROE -66.82% ROA -56.56%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -190.45 M
ROIC -51.25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.30
Interest Coverage -122.55 Asset Turnover 0.00
Working Capital 196.51 M Tangible Book Value 249.37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.00 Forward P/E N/A
P/B Ratio 0.00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0.05 Fwd Earnings Yield N/A
FCF Yield -19476.03%
Market Cap 977,889.0 Enterprise Value -74.97 M
Per Share
EPS (Diluted TTM) -2.01 Revenue / Share 0.00
FCF / Share -1.71 OCF / Share -1.71
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 85.36%
SBC-Adj. FCF -232.65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -223.12 M -258.75 M -245.60 M -221.86 M -169.07 M
EPS (Diluted) -2.01 -2.73 -2.92 -3.26 -2.67
Gross Profit — — — — —
Operating Income -231.75 M -273.21 M -259.66 M -224.34 M -167.25 M
EBITDA — — — — —
R&D Expenses 142.02 M 171.24 M 186.34 M 165.57 M 125.48 M
SG&A Expenses — — — — —
D&A 8.90 M 7.20 M 4.90 M — —
Interest Expense 1.89 M 1.89 M 1.88 M 1.86 M 2.98 M
Income Tax 0.0 — 0.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 330.45 M 527.70 M 566.34 M 551.81 M 497.02 M
Total Liabilities 53.23 M 64.47 M 73.77 M 62.12 M 42.30 M
Shareholders' Equity 277.22 M 463.23 M 492.57 M 489.69 M 454.72 M
Total Debt — — — — —
Cash & Equivalents 77.56 M 163.64 M 55.90 M 140.52 M 232.69 M
Current Assets 192.73 M 378.18 M 378.22 M 364.06 M 392.06 M
Current Liabilities 30.21 M 40.68 M 48.51 M 39.17 M 22.17 M